Ricky Cheung1, Siobhan O'Donnell1, Nawaf Madi2, Elliot Goldner3. 1. Public Health Agency of Canada, Ottawa, Ontario, Canada. 2. Rehabilitation and Mental Health, Canadian Institute for Health Information, Ottawa, Ontario, Canada. 3. Centre for Applied Research in Mental Health & Addiction, Faculty of Health Sciences, Simon Fraser University, Vancouver, British Columbia, Canada.
Abstract
INTRODUCTION: This study examined the association between time to diagnosis and sociodemographic and clinical characteristics as well as time to diagnosis and physical and mental health status, among Canadian adults with a self-reported mood and/or anxiety disorder diagnosis. METHODS: We used data from the 2014 Survey on Living with Chronic Diseases in Canada-Mood and Anxiety Disorders Component. The study sample (n=3212) was divided into three time to diagnosis subgroups: long (> 5 years), moderate (1-5 years) and short (< 1 year). We performed descriptive and multinomial multivariate logistic regression analyses. Estimates were weighted to represent the Canadian adult household population living in the 10 provinces with diagnosed mood and/or anxiety disorders. RESULTS: The majority (61.6%) of Canadians with a mood and/or anxiety disorder diagnosis reported having received their diagnosis more than one year after symptom onset (30.0% reported a moderate delay and 31.6% a long delay). Upon controlling for individual characteristics, we found significant associations between a moderate delay and having no or few physical comorbidities; a long delay and older age; and both moderate and long delays and early age of symptom onset. In addition, a long delay was significantly associated with "poor" or "fair" perceived mental health and the greatest number of activity limitations. CONCLUSION: These findings affirm that a long delay in diagnosis is associated with negative health outcomes among Canadian adults with mood and/or anxiety disorders. Time to diagnosis is particularly suboptimal among older adults and people with early symptom onset. Tailored strategies to facilitate an early diagnosis for those at greatest risk of a delayed diagnosis, especially for those with early symptom onset, are needed.
INTRODUCTION: This study examined the association between time to diagnosis and sociodemographic and clinical characteristics as well as time to diagnosis and physical and mental health status, among Canadian adults with a self-reported mood and/or anxiety disorder diagnosis. METHODS: We used data from the 2014 Survey on Living with Chronic Diseases in Canada-Mood and Anxiety Disorders Component. The study sample (n=3212) was divided into three time to diagnosis subgroups: long (> 5 years), moderate (1-5 years) and short (< 1 year). We performed descriptive and multinomial multivariate logistic regression analyses. Estimates were weighted to represent the Canadian adult household population living in the 10 provinces with diagnosed mood and/or anxiety disorders. RESULTS: The majority (61.6%) of Canadians with a mood and/or anxiety disorder diagnosis reported having received their diagnosis more than one year after symptom onset (30.0% reported a moderate delay and 31.6% a long delay). Upon controlling for individual characteristics, we found significant associations between a moderate delay and having no or few physical comorbidities; a long delay and older age; and both moderate and long delays and early age of symptom onset. In addition, a long delay was significantly associated with "poor" or "fair" perceived mental health and the greatest number of activity limitations. CONCLUSION: These findings affirm that a long delay in diagnosis is associated with negative health outcomes among Canadian adults with mood and/or anxiety disorders. Time to diagnosis is particularly suboptimal among older adults and people with early symptom onset. Tailored strategies to facilitate an early diagnosis for those at greatest risk of a delayed diagnosis, especially for those with early symptom onset, are needed.
Entities:
Keywords:
Survey on Living with Chronic Diseases in Canada; anxiety disorders; delayed diagnosis; health status; health surveys; mood disorders; population surveillance
Authors: S Lee; S C Fung; A Tsang; M Y Zhang; Y Q Huang; Y L He; Z R Liu; Y C Shen; R C Kessler Journal: Acta Psychiatr Scand Date: 2007-07 Impact factor: 6.392
Authors: R M Giaconia; H Z Reinherz; A B Silverman; B Pakiz; A K Frost; E Cohen Journal: J Am Acad Child Adolesc Psychiatry Date: 1994-06 Impact factor: 8.829
Authors: Monica Cepoiu; Jane McCusker; Martin G Cole; Maida Sewitch; Eric Belzile; Antonio Ciampi Journal: J Gen Intern Med Date: 2007-10-26 Impact factor: 5.128
Authors: Guilherme Borges; Philip S Wang; Maria Elena Medina-Mora; Carmen Lara; Wai Tat Chiu Journal: Am J Public Health Date: 2007-07-31 Impact factor: 9.308
Authors: Mathias Harrer; Sophia H Adam; Harald Baumeister; Pim Cuijpers; Eirini Karyotaki; Randy P Auerbach; Ronald C Kessler; Ronny Bruffaerts; Matthias Berking; David D Ebert Journal: Int J Methods Psychiatr Res Date: 2018-12-26 Impact factor: 4.035
Authors: Rina R Wehbe; Colin Whaley; Yasaman Eskandari; Ally Suarez; Lennart E Nacke; Jessica Hammer; Edward Lank Journal: JMIR Serious Games Date: 2022-05-19 Impact factor: 3.364
Authors: Berta Raventós; Andrea Pistillo; Carlen Reyes; Sergio Fernández-Bertolín; Maria Aragón; Anna Berenguera; Constanza Jacques-Aviñó; Laura Medina-Perucha; Edward Burn; Talita Duarte-Salles Journal: BMJ Open Date: 2022-04-08 Impact factor: 2.692
Authors: Rebecca Strawbridge; Paul McCrone; Andrea Ulrichsen; Roland Zahn; Jonas Eberhard; Danuta Wasserman; Paolo Brambilla; Giandomenico Schiena; Ulrich Hegerl; Judit Balazs; Jose Caldas de Almeida; Ana Antunes; Spyridon Baltzis; Vladimir Carli; Vinciane Quoidbach; Patrice Boyer; Allan H Young Journal: Eur Psychiatry Date: 2022-06-15 Impact factor: 7.156